Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-07 6:52 pm Sale |
2025-04-03 | 13G | Aldeyra Therapeutics, Inc. ALDX |
PERCEPTIVE ADVISORS LLC | 4,875,851 8.200% |
-4,400,000 (-47.44%) |
Filing History |
| 2024-11-14 4:50 pm Purchase |
2024-09-30 | 13G | Aldeyra Therapeutics, Inc. ALDX |
PERCEPTIVE ADVISORS LLC | 9,275,851 15.600% |
682,265 (+7.94%) |
Filing History |
| 2024-02-14 4:52 pm Unchanged |
2023-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX |
PERCEPTIVE ADVISORS LLC | 8,593,586 14.600% |
0 (Unchanged) |
Filing History |
| 2024-02-13 4:58 pm Purchase |
2023-12-29 | 13G | Aldeyra Therapeutics, Inc. ALDX |
The Vanguard Group | 3,927,597 6.680% |
3,927,597 (New Position) |
Filing History |
| 2024-01-29 5:25 pm Purchase |
2023-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX |
BLACKROCK INC BLK |
3,430,774 5.800% |
2,455,827 (+251.89%) |
Filing History |
| 2023-10-18 6:07 pm Sale |
2023-10-16 | 13G | Aldeyra Therapeutics, Inc. ALDX |
PERCEPTIVE ADVISORS LLC | 8,593,586 14.700% |
-2,756,499 (-24.29%) |
Filing History |
| 2023-10-04 3:22 pm Purchase |
2023-09-28 | 13G | Aldeyra Therapeutics, Inc. ALDX |
Knoll Capital Management LLC | 3,595,916 6.100% |
3,595,916 (New Position) |
Filing History |
| 2023-02-14 2:33 pm Purchase |
2022-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX |
PERCEPTIVE ADVISORS LLC | 11,350,085 19.400% |
1,446,206 (+14.60%) |
Filing History |
| 2023-02-03 11:25 am Sale |
2022-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX |
STATE STREET CORP STT |
173,281 0.300% |
-2,909,071 (-94.38%) |
Filing History |
| 2022-07-08 4:56 pm Sale |
2022-06-30 | 13G | Aldeyra Therapeutics, Inc. ALDX |
BLACKROCK INC BLK |
974,947 1.700% |
-2,253,864 (-69.80%) |
Filing History |
| 2022-02-14 3:45 pm Purchase |
2021-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX |
PERCEPTIVE ADVISORS LLC | 9,903,879 17.000% |
1,200,000 (+13.79%) |
Filing History |
| 2022-02-09 4:57 pm Purchase |
2021-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX |
STATE STREET CORP STT |
3,082,352 5.310% |
3,082,352 (New Position) |
Filing History |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX |
BLACKROCK INC BLK |
3,228,811 5.600% |
2,745,238 (+567.70%) |
Filing History |
| 2022-01-04 09:44 am Sale |
2021-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX |
Domain Partners VI L.P. | 0 0.000% |
-1,877,091 (Position Closed) |
Filing History |
| 2021-02-16 3:31 pm Purchase |
2020-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX |
PERCEPTIVE ADVISORS LLC | 8,703,879 19.100% |
2,418,421 (+38.48%) |
Filing History |
| 2021-02-16 3:00 pm Sale |
2020-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX |
683 Capital Management, LLC | 216,818 1.000% |
-1,510,882 (-87.45%) |
Filing History |
| 2021-02-12 08:30 am Sale |
2020-12-31 | 13G | Aldeyra Therapeutics, Inc. ALDX |
Prosight Management LP | 908,488 2.300% |
-875,545 (-49.08%) |
Filing History |
| 2020-07-13 4:30 pm Purchase |
2020-07-09 | 13G | Aldeyra Therapeutics, Inc. ALDX |
PERCEPTIVE ADVISORS LLC | 6,285,458 19.100% |
3,200,000 (+103.71%) |
Filing History |
| 2020-07-10 10:39 am Sale |
2020-06-30 | 13G | Aldeyra Therapeutics, Inc. ALDX |
BLACKROCK INC BLK |
483,573 1.600% |
-1,101,052 (-69.48%) |
Filing History |